Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Therapeutic activity of medicinal plants and their derivatives in controlling mosquito vector-borne diseases in north-east India

Choudhury A, Hasan I. AkiNik Publications. International Journal of Mosquito Research. 2023; 10 (1) : 07-14.
Download PDF
Publication

Lessons learned from the implementation of integrated serosurveillance of communicable diseases in the Americas

Saboyá-Díaz M, Castellanos LG, Morice A, et al. Pan American Health Organization. Revista Panamericana de Salud Pública. 2023;
Download PDF
Publication

WHO Timor-Leste Country Cooperation Strategy 2021-2025

World Health Organization, Country Office for Timor-Leste . World Health Organization. 2022;
Download PDF
Publication

Evaluation of opportunities to implement community-wide mass drug administration for interrupting transmission of soil-transmitted helminths infections in India

Aruldas K, Dawson K, Saxena M, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (3) : 1-21.
Download PDF
Publication

Determinants of Community Distrust of Drugs Deliverers in the Catchment Areas of Waihaong and Air Salobar Health Centers, Ambon

Siwtiory EPA, Titaley CR, Kailola NE, et al. Atlantis Press International BV. Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022). 2023;
Download PDF
Publication

Global Health Impact: A Model to Alleviate the Burden and Expand Access to Treatment of Neglected Tropical Diseases

Hassoun N, Cosler L. American Society of Tropical Medicine and Hygiene. The American Journal of Tropical Medicine and Hygiene. 2023;
Download PDF
Other

Skin-NTDs

Publication

Poverty-Related and Neglected Diseases Through a Gender Lens

DSW. 2023;
Download PDF
Publication

Challenges of implementation of the preventive chemotherapy neglected tropical diseases programme in Ghana.

Otoo D, Agbenu I, Nyamekye M, et al. PLoS neglected tropical diseases. 2023; 17 (2) : e0011116.
Download PDF
Publication

Contextual determinants of mass drug administration performance: Modelling fourteen years of lymphatic filariasis treatments in West Africa

Fuller BB, Harris V, Parker C, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2023; 17 (2) : e0011146.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 38
  • Next page ››
Subscribe to Lymphatic filariasis (Elephantiasis)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites NTD:

  • Infolep

© 2025 InfoNTD